A specific partnership initiative concerning the PMS and PMDD treatment app introduced from SUSMED, with the aim of obtaining joint research and development rights in Japan and exclusive sales rights, starting from preferential negotiation rights. The parties aim to launch the app and enter into a long-term sales agreement.